ArticlePloS one2014

Combination of TRAIL with bortezomib shifted apoptotic signaling from DR4 to DR5 death receptor by selective internalization and degradation of DR4.

Maxim L Bychkov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.